A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD

Conditions

• Chronic Obstructive Pulmonary Disease

Interventions

• DRUG: Ensifentrine
• DRUG: Placebo

Sponsor

Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA

Collaborators

• [object Object]